DayTwo
Walnut Creek
About DayTwo
DayTwo is a precision nutrition company that uses food as medicine to enable a path to remission for metabolic diseases including diabetes, prediabetes, clinical obesity, and NAFLD. DayTwo's groundbreaking scientific discovery, published in CELL (2015) and JAMA (2019) determined that people respond differently to the same food, thus knowing what food “works” for each person is crucial to an effective care plan. DayTwo uses gut microbiome sequencing (stool sample, akin to Cologuard) to create Food Prescriptions™ for each patient which balance blood sugar levels, improve energy, manage hunger, and help members lose weight. DayTwo virtual care solution is delivered through Certified Diabetes Care and Education Specialists and Registered Dietitians using a digital app to track progress and communicate with members.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $90.4M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2021)
- Website: daytwo.com
- Phone: [email protected]
Industries & Categories
Health Care, Nutrition, Personal Health, Wellness
Social Profiles
Canonical: https://fsome.com/organization/daytwo-96568 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.